We are live on ! Find out more
PC

Polar Capital Portfolio holdings

AUM $13.5B
1-Year Est. Return 55.9%
This Fund
S&P 500
This Quarter Est. Return
+7.6%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$8.89B
AUM Growth
+$1.45B
Cap. Flow
+$1.09B
Cap. Flow %
12.29%
Top 10 Hldgs %
26.12%
Holding
266
New
39
Increased
114
Reduced
52
Closed
27

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$63.8M
2
ALXN
Alexion Pharmaceuticals
ALXN
+$50M
3
VR
Validus Hold Ltd
VR
+$44.1M
4
PBYI icon
Puma Biotechnology
PBYI
+$33.5M
5
BIO icon
Bio-Rad Laboratories Class A
BIO
+$30.4M

Top Sells

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$59.3M
2
DHR icon
Danaher
DHR
+$44.2M
3
HOLX
Hologic
HOLX
+$42M
4
BDX icon
Becton Dickinson
BDX
+$40.7M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$38.7M

Sector Composition

Rank Sector Weight
1 Financials 21.97%
2 Healthcare 21.33%
3 Technology 19.13%
4 Communication Services 9.13%
5 Industrials 6.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNP icon
26
Union Pacific
UNP
$183B
$79.7M 0.9%
687,065
+29,822
+5% +$3.2M
PEP icon
27
PepsiCo
PEP
$186B
$77M 0.87%
691,451
– –
JPM icon
28
JPMorgan Chase
JPM
$939B
$76.9M 0.87%
804,943
+54,006
+7% +$4.98M
ALXN
29
DELISTED
Alexion Pharmaceuticals
ALXN
$74.8M 0.84%
533,000
+368,288
+224% +$50M
AMAT icon
30
Applied Materials
AMAT
$426B
$73.3M 0.83%
1,407,255
-8,780
-0.6% -$397K
AMGN icon
31
Amgen
AMGN
$203B
$72.2M 0.81%
387,500
+360,000
+1,309% +$63.8M
UNH icon
32
UnitedHealth
UNH
$382B
$71.7M 0.81%
366,300
– –
SPGI icon
33
S&P Global
SPGI
$126B
$71.7M 0.81%
458,520
– –
PFE icon
34
Pfizer
PFE
$140B
$68.5M 0.77%
2,021,511
– –
AET
35
DELISTED
Aetna Inc
AET
$67.9M 0.76%
427,276
– –
BAC icon
36
Bank of America
BAC
$435B
$65.8M 0.74%
2,597,072
+178,132
+7% +$4.32M
WFC icon
37
Wells Fargo
WFC
$261B
$63M 0.71%
1,141,536
+22,322
+2% +$1.19M
SU icon
38
Suncor Energy
SU
$77.7B
$62.7M 0.71%
1,606,876
-116,361
-7% -$3.71M
NEWR
39
DELISTED
New Relic, Inc.
NEWR
$58.4M 0.66%
1,171,573
-9,120
-0.8% -$431K
RTX icon
40
RTX Corp
RTX
$287B
$56M 0.63%
765,927
+83,981
+12% +$6.21M
DOX icon
41
Amdocs
DOX
$5.53B
$55.9M 0.63%
869,056
– –
AMD icon
42
Advanced Micro Devices
AMD
$851B
$55.3M 0.62%
4,337,875
+5,342
+0.1% +$69.7K
MDT icon
43
Medtronic
MDT
$107B
$55.2M 0.62%
709,241
-713,839
-50% -$59.3M
ZEN
44
DELISTED
ZENDESK INC
ZEN
$53.7M 0.6%
1,845,830
+60,000
+3% +$1.68M
SPLK
45
DELISTED
Splunk Inc
SPLK
$53.7M 0.6%
808,833
+66,030
+9% +$4.13M
JAZZ icon
46
Jazz Pharmaceuticals
JAZZ
$15.9B
$52.8M 0.59%
361,018
+128,500
+55% +$19.4M
MHK icon
47
Mohawk Industries
MHK
$6.9B
$52.8M 0.59%
213,133
+55,581
+35% +$13.8M
KEX icon
48
Kirby Corp
KEX
$7.95B
$51.7M 0.58%
783,392
– –
WRB icon
49
W.R. Berkley
WRB
$28B
$49.9M 0.56%
2,522,813
+821,813
+48% +$16.5M
ESNT icon
50
Essent Group
ESNT
$6.06B
$48.6M 0.55%
1,201,200
+56,500
+5% +$2.19M
1
2
3 4 5

Similar funds

ECM
ETrade Capital Management Arlington, Virginia $5.37B AUM 10.84% 1-Year Est. Return
FAAS
First Allied Advisory Services San Diego, California $2.98B AUM 15.89% 1-Year Est. Return
WAM
Wealthspire Advisors (Maryland) Potomac, Maryland $2.84B AUM 10.91% 1-Year Est. Return
FS
Feinberg Stephen $2.61B AUM 15.12% 1-Year Est. Return
NIMC
NWQ Investment Management Company Los Angeles, California $2.22B AUM 6.84% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return

Polar Capital's Q3 2017 Portfolio in Review

As of Q3 2017, Polar Capital held 266 positions worth $8.89B, up 20% from $7.43B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Polar Capital deployed $1.09B of net new capital in Q3 2017, opening 39 new positions and adding to 114 existing holdings. Its largest new stake was Puma Biotechnology: 360,000 shares worth $43.1M.

By sector, the portfolio is most concentrated in Financials at 22% of assets, down from 23% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Medtronic, an estimated $59.3M trimmed.

  • Polar Capital's largest Q3 2017 buy was Puma Biotechnology: 360,000 shares worth $43.1M.
  • Polar Capital added most to Amgen in Q3 2017, an estimated $63.8M increase.
  • Polar Capital's biggest Q3 2017 reduction was Medtronic, cutting an estimated $59.3M.
  • Polar Capital fully exited Hologic in Q3 2017, selling an estimated $42M.
  • Polar Capital's ten largest holdings make up 26% of its $8.89B portfolio in Q3 2017.
  • Polar Capital opened 39 new positions and closed 27 in Q3 2017.
  • Polar Capital's portfolio value rose 20% quarter-over-quarter to $8.89B.

Based on Polar Capital's 13F filing for Q3 2017, filed 14 Nov 2017.